LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS)-30-MONTH DATA FROM THE RELIANCE REGISTRY

被引：0

作者：

Kuemmerle-Deschner, J. B. ^{[1
]}

Kortus-Goetze, B. ^{[2
]}

Oommen, P. ^{[3
]}

Janda, A. ^{[4
]}

Rech, J. ^{[5
,6
]}

Kallinich, T. ^{[7
]}

Weller-Heinemann, F. ^{[8
]}

Horneff, G. ^{[9
]}

Foeldvari, I. ^{[10
]}

Schuetz, C. ^{[11
]}

Borte, M. ^{[12
]}

Braner, A. ^{[13
]}

Weber-Arden, J. ^{[14
]}

Blank, N. ^{[15
]}

机构：

[1] Univ Hosp Tuebingen, Div Pediat Rheumatol, Dept Pediat, Tubingen, Germany

[2] Univ Marburg, Div Nephrol, Marburg, Germany

[3] Heinrich Heine Univ Dusseldorf, Clin Pediat Hematol Oncol & Clin Immunol, Dusseldorf, Germany

[4] Univ Hosp Ulm, Dept Pediat, Ulm, Germany

[5] Friedrich Alexander Univ FAU, Erlangen, Germany

[6] Erlangen Nurnberg & Univ Erlangen, Dept Internal Med 3, Rheumatol & Immunol, Erlangen, Germany

[7] Charite Univ Med Berlin, Dept Pediat, Div Pulmonol Immunol & Crit Care Med, Berlin, Germany

[8] Klinikum Bremen Mitte, Hess Kinderklin, Bremen, Germany

[9] Asklepios Clin Sankt Augustin, St Augustin, Germany

[10] Ctr Pediat & Adolescence Rheumatol, Hamburg, Germany

[11] Tech Univ Dresden, Pediat, Med Fak Carl Gustav Carus, Dresden, Germany

[12] Hosp St Georg GmbH Leipzig, Immuno Deficiency Ctr Leipzig IDCL, Leipzig, Germany

[13] Univ Hosp Frankfurt, Dept Med 2, Rheumatol, Frankfurt, Germany

[14] Novartis Pharma GmbH, Nurnberg, Germany

[15] Univ Heidelberg Hosp, Rheumatol, Heidelberg, Germany

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷

关键词：

D O I：

10.1136/annrheumdis-2021-eular.3716

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

OP0092

引用

页码：50 / 51

页数：2

共 50 条

[1] LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES-36-MONTH DATA FROM THE RELIANCE REGISTRY
Kuemmerle-Deschner, J. B.
Kortus-Goetze, B.
Oommen, P.
Janda, A.
Rech, J.
Schuetz, C.
Kallinich, T.
Weller-Heinemann, F.
Horneff, G.
Foeldvari, I.
Meier, F.
Borte, M.
Krickau, T.
Weber-Arden, J.
Blank, N.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 346 - 347
[2] LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS)-4-YEARS DATA FROM THE RELIANCE REGISTRY
Kuemmerle-Deschner, J. B.
Kortus-Goetze, B.
Schuetz, C.
Oommen, P.
Janda, A.
Rech, J.
Weller-Heinemann, F.
Kallinich, T.
Pankow, A.
Horneff, G.
Foeldvari, I.
Wasiliew, P.
Borte, M.
Fiene, M.
Meier, F.
Krickau, T.
Andreica, I.
Weber-Arden, J.
Blank, N.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 167 - 167
[3] Influence of Canakinumab Dosing on Long-term Efficacy and Safety in Patients with Cryopyrin-associated Periodic Syndromes (CAPS)-30-months Interim Analysis of the RELIANCE Registry
Kuemmerle-Deschner, Jasmin
Kortus-Goetze, Birgit
Oommen, Prasad T.
Janda, Ales
Rech, Juergen
Kallinich, Tilmann
Weller-Heinemann, Frank
Horneff, Gerd
Foeldvari, Ivan
Schuetz, Catharina
Borte, Michael
Braner, Axel
Weber-Arden, Julia
Blank, Norbert
ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 381 - 382
[4] 3-years Safety and Efficacy Outcomes of Canakinumab Treatment in Cryopyrin-associated Periodic Syndromes (CAPS) - Data from the RELIANCE Registry
Kuemmerle-Deschner, Jasmin B.
Kortus-Goetze, Birgit
Oommen, Prasad T.
Janda, Ales
Rech, Juergen
Schuetz, Catharina
Kallinich, Tilmann
Weller-Heinemann, Frank
Horneff, Gerd
Foeldvari, Ivan
Meier, Florian
Borte, Michael
Krickau, Tobias
Weber-Arden, Julia
Blank, Norbert
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1613 - 1614
[5] Canakinumab in cryopyrin-associated periodic syndromes (caps). A clinical case
Garcia Fernandez, C.
Gomez Pena, C.
Belda Rustarazo, S.
Valle Corpas, M.
Gonzalez Medina, M. D. C.
Davila Fajardo, C.
Blanquez Martinez, D.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 539 - 539
[6] Long-term safety and effectiveness of canakinumab therapy in patients with cryopyrin-associated periodic syndrome: results from the β-Confident Registry
Walker, Ulrich A.
Tilson, Hugh H.
Hawkins, Philip N.
van der Poll, Tom
Noviello, Stephanie
Levy, Jeremy
Vritzali, Eleni
Hoffman, Hal M.
Kuemmerle-Deschner, Jasmin B.
RMD OPEN, 2021, 7 (02):
[7] LONG-TERM EFFECTIVENESS OF CANAKINUMAB IN PATIENTS WITH CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME
Kuemmerle-Deschner, J. B.
Blank, Norbert
Borte, Michael
Foeldvari, Ivan
Horneff, Gerd
Oommen, Prasad
Schuetz, Catharina
Weller-Heinemann, Frank
Weber-Arden, Julia
Kallinich, Tilmann
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 156 - 157
[8] Long-term safety and efficacy of Canakinumab in cryopyrin-associated periodic syndrome (CAPS) patients: Results from beta-confident registry
Kuemmerle-Deschner J.
Hoffman H.
Hawkins P.N.
van der Poll T.
Walker U.A.
Speziale A.
Tilson H.H.
Pediatric Rheumatology, 13 (Suppl 1)
[9] LONG-TERM SAFETY OF CANAKINUMAB IN AUTOINFLAMMATORY PERIODIC FEVER SYNDROMES-48-MONTH DATA FROM THE RELIANCE REGISTRY
Kuemmerle-Deschner, J. B.
Henes, J.
Kortus-Goetze, B.
Oommen, P.
Pankow, A.
Kallinich, T.
Krickau, T.
Schuetz, C.
Horneff, G.
Foeldvari, I.
Rech, J.
Weller-Heinemann, F.
Janda, A.
Hufnagel, M.
Meier, F.
Dressler, F.
Borte, M.
Andreica, I.
Wasiliew, P.
Fiene, M.
Windschall, D.
Weber-Arden, J.
Blank, N.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1153 - 1153
[10] Dosage and Treatment of Patients with Cryopyrin-associated periodic Syndromes (CAPS) with Canakinumab
Hofer, F.
Endres, T.
Kortus-Goetze, B.
Blank, N.
Weissbarth-Riedel, E.
Schuetz, C.
Kallinich, T.
Krause, K.
Rietschel, C.
Horneff, G.
Kuemmerle-Deschner, J.
ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 132 - 133

← 1 2 3 4 5 →